REDERGIN 0.3mg / ml injectible solution medication leaflet

C04AE01 codergocrine • Cardiovascular system | Peripheral vasodilators | Ergot alkaloids

Codergocrine is an ergot derivative used for the treatment of cerebral and peripheral circulatory disorders. It works by improving blood flow and reducing vascular resistance, helping to alleviate associated symptoms.

The medication is administered orally or by injection, as directed by a doctor. It is important for patients to follow the treatment regimen and inform the doctor about any other medications being used.

Patients should be aware of potential side effects, such as nausea, dizziness, or allergic reactions. It is important to inform the doctor of any unusual symptoms.

Common side effects include nausea, dizziness, and headaches. In rare cases, severe reactions such as vasospasm or allergic reactions may occur. Patients should be informed of these risks before use.

General data about REDERGIN 0.3mg / ml

Substance: codergocrine

Date of last drug list: 01-07-2013

Commercial code: W01423001

Concentration: 0.3mg / ml

Pharmaceutical form: injectible solution

Quantity: 50

Product type: generic

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Pharmaceutical forms available for codergocrine

Concentrations available for codergocrine

0.1%, 0.3mg/ml, 1mg/ml

Other substances similar to codergocrine